UCLB Investor Breakfasts 2008
APRIL BREAKFAST: CANCER / STEM CELLS
Date: April 29th
Venue: The Globe Theatre, London
Full House at the Globe Theatre
Many thanks to all who attended our April breakfast, which focused on novel advances in cancer treatments and stem cell technologies.
Very positive feedback suggests the event generated a lot of interest and discussion, and gave attendees an early opportunity to learn about the potentially highly rewarding technology pipeline in these areas. Judging by the comments we received, we're delighted you found it a useful event.
For those who were unable to attend, we're sorry not to have seen you, but please click on the links below to download the presentations that you missed.
- Stem Cell Therapy for Lung Cancer
- GENEX Biosystems - An Injectable Delivery System for Tumour Specific Delivery of Gene-Based Therapeutics
- Spirogen – Taking a novel drug from Spirogen’s platform for treating drug resistant cancer into phase II clinical trials
- Olfactory Ensheathing Cells: Potential for Repairing Spinal Cord and Spinal Root Injuries
- In Vivo Cartilaginous Bio-Resurfacing of the Acetabulum
- PACT: A new approach to PhotoActivated ChemoTherapy
- Rapid Optical Diagnosis of Breast Cancer
- Tumour-activated human NK cells – potential for “off-the-shelf” immunotherapy
If you have any queries on projects or companies presented, please do not hesitate to get in touch. We hope to see you at our next Investor Breakfast at 8am on June 24th where we will feature Physical Sciences, Engineering and Environmental Opportunities at UCL.
